comparemela.com

Latest Breaking News On - Astellas pharma - Page 2 : comparemela.com

Merck Reportedly Nearing $1 3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co (NYSE:MRK)

Merck & Co is reportedly on the verge of acquiring EyeBio, an eye-drug company, for a sum of $1.3 billion. This acquisition is expected to significantly expand Merck's presence in the rapidly growing eye-care market.

Seventh Annual TGaS Advisors Best of Benchmark Award Winners Announced

Sakai Chemical Industry : NOTICE OF THE 129TH ORDINARY GENERAL MEETING OF SHAREHOLDERS [

Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the.

Merck Sees Pipeline Diversification Opportunity in $1 3B EyeBio Acquisition

Merck Sees Pipeline Diversification Opportunity in $1 3B EyeBio Acquisition
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Wave of Antibody-Drug Conjugates Poised to Change Treatment Paradigms Across Multiple Cancers

Wave of Antibody-Drug Conjugates Poised to Change Treatment Paradigms Across Multiple Cancers
ajmc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajmc.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.